| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.8M | +0.0% |
| R&D Expense | $38K | -99.5% |
| SG&A Expense | $5.1M | -34.1% |
| Operating Income | -$5.2M | +47.1% |
| Income Tax | $0 | — |
| Net Income | -$5.2M | +46.0% |
| EPS (Basic) | -$1.41 | +46.2% |
| EPS (Diluted) | -$1.41 | +46.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.1M | -57.1% |
| Current Assets | $4.1M | -58.4% |
| Total Assets | $4.1M | -58.4% |
| Current Liabilities | $329K | -64.6% |
| Total Liabilities | $329K | -67.0% |
| Stockholders' Equity | $3.8M | -57.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.4M | +49.3% |
| Capital Expenditures | $398K | +0.0% |
| Investing Cash Flow | -$398K | +0.0% |
| Free Cash Flow | -$5.8M | +47.5% |